NO996453L - Nye tricykliske forbindelser med mettede ringer, samt medisinske blandinger inneholdende forbindelsene - Google Patents

Nye tricykliske forbindelser med mettede ringer, samt medisinske blandinger inneholdende forbindelsene

Info

Publication number
NO996453L
NO996453L NO996453A NO996453A NO996453L NO 996453 L NO996453 L NO 996453L NO 996453 A NO996453 A NO 996453A NO 996453 A NO996453 A NO 996453A NO 996453 L NO996453 L NO 996453L
Authority
NO
Norway
Prior art keywords
hydrogen atom
compounds
atom
amino
well
Prior art date
Application number
NO996453A
Other languages
English (en)
Other versions
NO996453D0 (no
Inventor
Shiro Miyoshi
Kohei Ogawa
Original Assignee
Asahi Chemical Ind
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asahi Chemical Ind filed Critical Asahi Chemical Ind
Publication of NO996453D0 publication Critical patent/NO996453D0/no
Publication of NO996453L publication Critical patent/NO996453L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/91—Dibenzofurans; Hydrogenated dibenzofurans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/80—[b, c]- or [b, d]-condensed
    • C07D209/82—Carbazoles; Hydrogenated carbazoles
    • C07D209/88—Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/76—Dibenzothiophenes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Forbindelser som representeres ved den generelle formel (I), eller salter derav: hvor R representerer et hydrogenatom eller metyl, R1 betyr et hydrogenatom, halogenatom, hydroksy, benzyloksy, amino eller hydroksymetyl, R2 betyr et hydrogenatom, hydroksy- metyl, NHR3, SO2NR4R4' eller nitro, hvor R1 er et hydrogen- atom, metyl, SO2R5, formyl eller CONHRS|, med R5 er lavere alkyl, benzyl eller NR4R4', og 4 og R4' kan være identiske eller forskjellige fra hverandre for et hydrogenatom, lavere alkyl eller benzyl, RS| representerer et hydrogen- atom eller lavere alkyl, og Rs representerer et hydrogen- atom eller lavere alkyl, n er l eller 2, og X er et sekun- dært nitrogenatom, oksygenatom eller svovelatom og, i til- felle at n er l, betyr en av R7 og R8 er et hydrogenatom og den andre er et hydrogenatom, amino, acetylamino eller hyd- roksy, eller, i tilfelle at n er 2, er R8 et hydrogenatom og R7 er et hydrogenatom, amino, acetyl amino eller hyd- roksy, og *1 betyr et usymmetrisk karbonatom og *2 og *3 viser at karbonatomet er asymmetrisk, forutsatt at R' og R8 ikke betyr et hydrogenatom. Forbindelsene er terapeutisk aktive.
NO996453A 1997-07-03 1999-12-23 Nye tricykliske forbindelser med mettede ringer, samt medisinske blandinger inneholdende forbindelsene NO996453L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP17819797 1997-07-03
PCT/JP1998/002680 WO1999001431A1 (en) 1997-07-03 1998-06-17 Novel tricyclic compounds having saturated rings and medicinal compositions containing the same

Publications (2)

Publication Number Publication Date
NO996453D0 NO996453D0 (no) 1999-12-23
NO996453L true NO996453L (no) 2000-03-03

Family

ID=16044289

Family Applications (1)

Application Number Title Priority Date Filing Date
NO996453A NO996453L (no) 1997-07-03 1999-12-23 Nye tricykliske forbindelser med mettede ringer, samt medisinske blandinger inneholdende forbindelsene

Country Status (9)

Country Link
US (1) US6172099B1 (no)
EP (1) EP0997458A4 (no)
KR (1) KR100335169B1 (no)
AU (1) AU735249B2 (no)
CA (1) CA2296104A1 (no)
DE (1) DE997458T1 (no)
ES (1) ES2149742T1 (no)
NO (1) NO996453L (no)
WO (1) WO1999001431A1 (no)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1105514B1 (en) 1998-08-04 2008-02-06 Metabolix, Inc. Polyhydroxyalkanoate production from polyols
TW519537B (en) * 1999-03-26 2003-02-01 Asahi Chemical Ind Process for the preparation of tricylic amino-alcohol derivatives
KR20020005648A (ko) * 1999-04-01 2002-01-17 야마모토 카즈모토 삼환성 아미노알콜 유도체의 아지드를 경유하는 제조법
CN1360574A (zh) * 1999-07-09 2002-07-24 旭化成株式会社 制备三环氨基醇衍生物的方法
WO2001017962A1 (en) * 1999-09-03 2001-03-15 Asahi Kasei Kabushiki Kaisha Processes for the preparation of tricyclic amino alcohol derivatives
KR20020068513A (ko) * 1999-10-04 2002-08-27 아사히 가세이 가부시키가이샤 삼환성 아미노 알코올 유도체의 용해성 개선 방법
EP1238973A4 (en) * 1999-12-16 2003-01-22 Asahi Chemical Ind NEW SUBSTITUTED TRICYCLIC COMPOUNDS
EP1258253A1 (en) * 2000-01-28 2002-11-20 Asahi Kasei Kabushiki Kaisha Novel remedies with the use of beta3 agonist
WO2001083451A1 (en) * 2000-04-28 2001-11-08 Asahi Kasei Kabushiki Kaisha Novel bicyclic compounds
GB0010757D0 (en) 2000-05-05 2000-06-28 Astrazeneca Ab Chemical compounds
GB0029562D0 (en) * 2000-12-04 2001-01-17 Novartis Ag Organic compounds
WO2002074306A1 (en) * 2001-03-19 2002-09-26 Asahi Kasei Kabushiki Kaisha Remedies for fatty liver
ES2370634T3 (es) * 2001-08-31 2011-12-21 Novartis Ag Isómeros ópticos de un metabolito de iloperidona.
GB0121941D0 (en) 2001-09-11 2001-10-31 Astrazeneca Ab Chemical compounds
EP1447400B1 (en) 2001-10-25 2008-09-17 Asahi Kasei Pharma Corporation Bicyclic compound
KR20110050733A (ko) 2008-10-09 2011-05-16 아사히 가세이 파마 가부시키가이샤 인다졸 유도체
AU2009301798B2 (en) 2008-10-09 2012-03-01 Asahi Kasei Pharma Corporation Indazole compound
US20100222404A1 (en) * 2008-11-04 2010-09-02 Asahi Kasei Pharma Corporation Indazole derivative dihydrochloride
ES2394349B1 (es) 2012-08-29 2013-11-04 Fundación Centro Nacional De Investigaciones Cardiovasculares Carlos Iii Uso de agonistas selectivos de receptores beta-3 adrenérgicos para el tratamiento de hipertensión pulmonar

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2332010A1 (fr) 1975-11-18 1977-06-17 Continental Pharma Amino-alcool heterocyclique, son sel et son procede de preparation
JPS5553262A (en) 1978-10-17 1980-04-18 Yamanouchi Pharmaceut Co Ltd Phenylethanolamine derivative
US4338333A (en) 1979-06-16 1982-07-06 Beecham Group Limited Ethanamine derivatives their preparation and use in pharmaceutical compositions
JPS5950671B2 (ja) 1982-08-26 1984-12-10 山之内製薬株式会社 フェニルエタノ−ルアミン誘導体およびその製造法
JPS6016980A (ja) * 1983-07-06 1985-01-28 Nippon Soda Co Ltd ヘキサヒドロジベンゾフラン誘導体及びその製造方法
GB8419797D0 (en) 1984-08-03 1984-09-05 Beecham Group Plc Compounds
GB8926083D0 (en) 1989-11-17 1990-01-10 Ici Plc Therapeutic agents
US5061727A (en) 1990-05-04 1991-10-29 American Cyanamid Company Substituted 5-(2-((2-aryl-2-hydroxyethyl)amino)propyl)-1,3-benzodioxoles
US5100891A (en) * 1991-01-18 1992-03-31 Hoechst-Roussel Pharmaceuticals Inc. Substituted 1,2,3,4-tetrahydrocyclopent[b]indoles, 1,2,3,3a,4,8a-hexahydrocyclopent[B]indoles and related compounds
ATE154935T1 (de) 1993-06-14 1997-07-15 Pfizer Zweite amine als antidiabetische mittel und für die behandlung von fettleibigkeit
US5776983A (en) 1993-12-21 1998-07-07 Bristol-Myers Squibb Company Catecholamine surrogates useful as β3 agonists
US5541197A (en) 1994-04-26 1996-07-30 Merck & Co., Inc. Substituted sulfonamides as selective β3 agonists for the treatment of diabetes and obesity
JPH08165276A (ja) 1994-12-14 1996-06-25 Dainippon Pharmaceut Co Ltd 2−アルキルアミノ−1−フェニルエタノール誘導体
WO1996035670A1 (en) * 1995-05-10 1996-11-14 Pfizer Inc. β-ADRENERGIC AGONISTS
WO1997025311A1 (en) 1996-01-10 1997-07-17 Asahi Kasei Kogyo Kabushiki Kaisha Novel tricyclic compounds and drug compositions containing the same
WO1998012170A1 (en) * 1996-09-20 1998-03-26 Yamanouchi Pharmaceutical Co., Ltd. Novel tricyclic fused ring derivatives

Also Published As

Publication number Publication date
CA2296104A1 (en) 1999-01-14
AU735249B2 (en) 2001-07-05
EP0997458A4 (en) 2003-03-05
WO1999001431A1 (en) 1999-01-14
NO996453D0 (no) 1999-12-23
AU8033498A (en) 1999-01-25
ES2149742T1 (es) 2000-11-16
DE997458T1 (de) 2001-03-01
KR100335169B1 (ko) 2002-05-04
KR20010015528A (ko) 2001-02-26
US6172099B1 (en) 2001-01-09
EP0997458A1 (en) 2000-05-03

Similar Documents

Publication Publication Date Title
AU537414B2 (en) Pyroglutamic acid derivatives
NO883487D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive heterocykliske forbindelser.
ES8305356A1 (es) Un procedimiento para la produccion de un derivado de carbostirilo
NZ511394A (en) N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
DK0592439T3 (da) Aminosulfonylcarbamater
FI943646A0 (fi) Bentsosyklohepteenejä, bentsoksepiinejä bentsotiepiinejä
GB0018272D0 (en) Chemical compounds IV
DE69522703D1 (de) Aminotetrazol-derivate verwendbar als stickstoff-oxid-synthase inhibitoren
ES2051650A1 (es) Procedimiento para preparar un limpiador de oxigeno activo.
AU534786B2 (en) 4-phenoxypiperidines
LU90758I2 (fr) Almotriptan et ses sels pharmaceutiquement acceptables
FI860945A0 (fi) ^-laktamantibiotika, foerfarande foer deras framstaellning och deras anvaendning som och i laekemedel.
MY117092A (en) Chemotherapeutic pyrrolocarbazole derivatives
SE8505887D0 (sv) Indoler
ES2102327A1 (es) Nuevos derivados de 2,2,6,6-tetrametilpiperidina para utilizarse como agentes estabilizantes para materiales organicos contra la luz, el calor, y la oxidacion. n
ES2128572T3 (es) Utilizacion de los derivados de cefem como agentes antimetastaticos.
DK37790A (da) Indolderivater, deres fremstilling og anvendelse
ES2182523T3 (es) Derivados de indolilo como agentes serotonergicos.
ZA918083B (en) Indole derivatives
KR970706280A (ko) 5-HT1A 길항제로서의 비사이클릭 카복스아미드(Bicyclic carboxamides as 5-HT1 antagonists)
AU531550B2 (en) Ethers of 1-(2-propynyloxy)-2-amino-3-propanol
ATE206431T1 (de) Antifungal fusacandine
ES457528A1 (es) Procedimiento para la obtencion de compuestos oxotio.
RO85279B (ro) Procedeu pentru prepararea unor derivati de 1, 2, 3-tiadiazol-5-il-uree
JO1832B1 (en) Therapeutic agents

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application